BNP Paribas Exane upgraded Hypoport (HYPOF) to Outperform from Neutral with a EUR 210 price target The firm sees strong earnings growth ahead of the company.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds